Repeated doses of diclofenac etalhyaluronate (DF-HA) yield improvements in knee osteoarthritis (OA) pain without major safety signals, with the effect occurring as early as week 1, according to the results of a phase II trial.
Patients with psoriatic arthritis (PsA) may show residual disease activity (RDA), according to a study. Very low disease activity (VLDA) appears to be the most stringent criterion to identify patients in the absence of RDA.
Obese rheumatoid arthritis (RA) patients taking conventional synthetic (cs-) or biological disease-modifying antirheumatic drugs (DMARDs) see lower rates of disease remission, a recent study has shown.
The association between bronchiectasis and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) does not appear to be incidental and is mostly correlated with myeloperoxidase (MPO)-ANCA, suggests a recent study.
Patients with hand osteoarthritis (HOA) who have or develop diabetes mellitus (DM) and/or cardiovascular disease (CVD) appear to experience a lower likelihood of symptomatic and functional improvement over time, suggests a study. This indicates the effect of comorbid CVD and DM on the clinical and radiographic course of HOA.
Dehydroepiandrosterone supplementation confers benefits for quality of life (QoL) but not for disease activity relative to placebo in premenopausal women with rheumatoid arthritis (RA), a study has found.